Health Care

Morgan Stanley lowered McKesson Corporation (NYSE: MCK) price target from $175 to $142. McKesson shares closed at $134.88 on Monday. Deutsche Bank lowered American Airlines Group Inc. (NASDAQ: AAL) price target from $60 to $43. American Airlines shares closed at $38.36 on Monday. Raymond James...

Gainers Neuronetics, Inc. (NASDAQ: STIM) shares jumped 63.41 percent to close at $27.78. Neurostimulation device maker Neuronetics priced its IPO of 5.5 million shares at $17 per share. Tricida, Inc. (NASDAQ: TCDA) climbed 36.84 percent to close at $26.00. Tricida priced its 11.7 million share...

Gainers New Concept Energy, Inc. (NYSE: GBR) jumped 81.69 percent to $2.58 after Realty Advisors disclosed a new 2.81 percent stake in the company. Neuronetics, Inc. (NASDAQ: STIM) shares shot up 47 percent to $25.02. Neurostimulation device maker Neuronetics priced its IPO of 5.5 million shares...

Top Upgrades Goldman Sachs upgraded DCP Midstream, LP (NYSE: DCP) from Neutral to Buy. DCP Midstream shares rose 1 percent to close at $39.26 on Tuesday. Oppenheimer upgraded General Electric Company (NYSE: GE) from Underperform to Perform. General Electric shares rose 1.66 percent to $13.97 in...

Gainers Ability Inc. (NASDAQ: ABIL) shares surged 110.65 percent to close at $4.55 on Thursday. AVROBIO, INC. (NASDAQ: AVRO) shares rose 64.21 percent to close at $31.20. AVROBIO priced its 5.24 million share IPO at $19 per share. Xenetic Biosciences, Inc. (NASDAQ: XBIO) shares jumped 50.63...

Gainers Xenetic Biosciences, Inc. (NASDAQ: XBIO) shares climbed 163.6 percent to $6.3010. Ability Inc. (NASDAQ: ABIL) gained 73.6 percent to $3.7490. AVROBIO, INC. (NASDAQ: AVRO) shares rose 70.3 percent to $32.35. AVROBIO priced its 5.24 million share IPO at $19 per share. Stellar...

Gainers CLPS Incorporation (NASDAQ: CLPS) jumped 56.13 percent to close at $16.80 on Wednesday after the company released a letter to shareholders. The China-based company said it's working on "enhancing its original financial technology service offerings to expand to international...

Gainers Caladrius Biosciences Inc (NASDAQ: CLBS) climbed 44.6 percent to $9.5601. Caladrius Biosciences shares climbed over 67 percent Tuesday after announcing the company’s CD34+ cell therapy program received FDA regenerative medicine advanced therapy designation for treating refractory...

Following the market opening Wednesday, the Dow traded down 0.04 percent to 24,690.78 while the NASDAQ climbed 0.51 percent to 7,765.06. The S&P also rose, gaining 0.15 percent to 2,766.70. Leading and Lagging Sectors Wednesday morning, the information technology shares surged 0.61 percent....

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed...